Lifescience

 The global Rosuvastatin Calcium market is experiencing steady growth, driven by rising cardiovascular disease (CVD) prevalence, increasing statin prescriptions, and expansion of generic drug manufacturing. Valued at USD 519 million in 2024 , the market is projected to reach USD 693 million by 2032 , exhibiting a compound annual growth rate (CAGR) of 4.3% . This growth reflects the critical role of rosuvastatin calcium in managing cholesterol levels and reducing cardiovascular risk worldwide. Get free sample of this report at :    https://www.24lifesciences.com/download-sample/1932/rosuvastatin-calcium-market-market  What is Rosuvastatin Calcium? Rosuvastatin Calcium (CAS 147098-20-2) is an active pharmaceutical ingredient (API) classified as a statin drug. It inhibits HMG-CoA reductase , lowering LDL cholesterol while increasing HDL cholesterol. As the key component of blockbuster drugs like Crestor® , rosuvastatin is available in tablet and capsule formulatio...

  The global vegetarian softgel capsules market size was valued at USD 398 million in 2024. The market is projected to grow from USD 419 million in 2025 to USD 571 million by 2032, exhibiting a CAGR of 5.4% during the forecast period. Get free sample of this report at :  https://www.24lifesciences.com/download-sample/1947/vegetarian-softgel-capsules-market-market   Vegetarian softgel capsules are plant-based encapsulation solutions designed as alternatives to traditional gelatin-based softgels. These capsules consist of a solid outer shell surrounding a liquid or semi-solid active ingredient, which can be incorporated into either the shell or inner fill. Unlike animal-derived gelatin capsules, vegetarian softgels are made from plant polysaccharides (such as pullulan), starches, or hydroxyl propyl methyl celluloses (HPMC), making them GMO-free and suitable for Halal/Kosher certification. The market is witnessing steady growth driven by increasing consumer preference for pl...